GLG Institute is transforming the way the world’s top executives share expertise, learn and accelerate success. Senior executives learn fastest through conversation with other professionals who can share relevant experience and hard-won perspectives. GLG Institute is designed to create those conversations. We recruit the world’s best operators, leaders, and policy makers to serve as Advisors to GLG Institute Members.
GLG Institute membership is by nomination only.
GLG Institute Advisors comprise more than 350 C-suite executives and policy leaders who share their industry expertise with Institute Members. Below are just a few of the diverse leaders who serve as GLG Institute Advisors.
Chairman, GLG Institute Healthcare
Former CEO and Chairman of the Executive Committee, UCB
Chairman, GLG Institute
Former Chairman and CEO, Pfizer
Former Governor of Vermont and Former Chairman of the DNC
Former President, McDonald’s USA
Former President & CEO, Walmart Americas
Chief Marketing Officer, NFL; former President & CEO, Pepsi North America
Former Executive Director, European Medicines Agency (EMA)
Former Administrator, CMS and Former Commissioner, FDA
Former President, Commercial Operations & COO, Genentech
Former Chairman & CEO, Johnson & Johnson
Former CEO, Highmark
How It Works
GLG Institute Members are paired with dedicated GLG Relationship Managers who arrange 1:1 meetings throughout the year with precisely the right Advisors. Among other topics, Members and Advisors confer on:
Strategic and operational challenges
Communication and stakeholder management
Members typically engage in two conversations per month with Advisors and attend 1-2 small roundtable meetings per year with fellow Members on shared topics of interest.
Hear from some of GLG Institute’s Members and Advisors:
Former Walmart, The Americas CEO, Craig Herkert explains the transformation of traditional CPG brands and the future of the supermarket experience.
SVP, Alzheimer's Disease Therapeutic Area at Biogen, discusses evolving into leadership roles, the changing healthcare industry, and the benefits of new perspectives.
Former Lockheed Martin executive Ray O. Johnson discusses cyber security strategy, global security solutions, and the aerospace industry.
Boston Biomedical CEO Pat Andrews on the drug discovery process and value of connecting with a wide-range of subject matter experts.
GLG Institute Members are accomplished executives who seek the personalized access to industry leaders that GLG Institute facilitates. They are CEOs, Presidents, EVPs, and SVPs, and they come from the most prestigious companies in the world, including:
- Becton Dickinson
- Boston Biomedical
- Daiichi Sankyo
- Eli Lilly
- EMD Serono
- Flen Pharma
- Jazz Pharmaceuticals
- Johnson & Johnson
- Novo Nordisk
- OncoArendi Therapeutics
- Otsuka Pharmaceuticals
- Siemens Healthineers
What our Members are saying
“Meeting with GLG Institute Advisors gives me actionable ideas and practical insights that I can immediately integrate back into my work, whether it’s preparing for a conversation with my board or providing new incentives for leading my team. These insights have enabled me to be a better leader.”
Habib Dable, President and CEO, Acceleron Pharma
“GLG Institute understands that the metrics for success are individualized. Working with my relationship manager, each connection I make ties in to my objectives and propels my growth.”
Michele Holcomb, Executive Vice President, Strategy and Corporate Development, Cardinal Health
"My meetings with GLG Advisors have been invaluable, as they gave me an outside perspective on critical aspects of my job and have helped my personal development. I have also met great leaders that I would have never been exposed to in such short time!"
Carsten Thiel, Former Executive Vice President & Chief Commercial Officer, Alexion
"The GLG Institute community provides unique opportunities for tailored conversations with respected CEOs and subject matter experts. Speaking to Advisors who have been in my shoes allows me to make better and accelerated business decisions in an increasingly complex environment.”
Sanjiv Patel, President and CEO, Relay Therapeutics